Additional Information
Book Details
Abstract
Get a quick, expert overview of the many key facets of today’s otolaryngology practice with this concise, practical resource. Dr. Luke Rudmik and a leading team of experts in the field address high-interest clinical topics in this fast-changing field.
- Presents an evidence-based, clinical approach to leading topics in otolaryngology.
- Covers key topics such as management of vertigo; management of adult sensorineural hearing loss; reflux in sinusitis; balloon catheter dilation in rhinology; epistaxis; functional rhinoplasty; sublingual immunotherapy for allergic rhinitis; pediatric obstructive sleep apnea; pediatric tonsillectomy; evaluation and management of unilateral vocal fold paralysis; management of hoarseness; endoscopic skull base resection for malignancy; management of glottic cancer; management of well-differentiated thyroid cancer; and management of the clinical node-negative neck in early stage oral cavity squamous cell carcinoma.
- Consolidates today’s available information and experience in this challenging area into one convenient resource.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
Evidence-Based Clinical Practice in Otolaryngology | i | ||
Evidence-Based Clinical Practice in Otolaryngology | iii | ||
Copyright | iv | ||
List of Contributors | v | ||
Contents | ix | ||
1 - Evidence-Based Practice: Management of Acute Vertigo | 1 | ||
BENIGN PAROXYSMAL POSITIONAL VERTIGO | 1 | ||
Introduction | 1 | ||
Pathophysiology | 1 | ||
Diagnosis | 2 | ||
Posterior canal benign paroxysmal positional vertigo | 2 | ||
Lateral canal benign paroxysmal positional vertigo | 3 | ||
Superior canal benign paroxysmal positional vertigo | 3 | ||
Management | 4 | ||
Physical maneuvers | 4 | ||
Surgery for refractory benign paroxysmal positional vertigo | 6 | ||
Vestibular rehabilitation therapy | 6 | ||
VESTIBULAR NEURITIS | 6 | ||
Introduction | 6 | ||
Pathophysiology | 6 | ||
Diagnosis | 7 | ||
Management | 7 | ||
Vestibular suppressants | 7 | ||
Antiemetics | 8 | ||
Betahistine | 8 | ||
Antivirals | 8 | ||
Steroids | 8 | ||
Vestibular rehabilitation therapy | 8 | ||
REFERENCES | 8 | ||
2 - Management of Adult Sensorineural Hearing Loss | 15 | ||
OVERVIEW | 15 | ||
ETIOLOGIES | 15 | ||
Age-Related Hearing Loss (Presbycusis) | 15 | ||
Autoimmune | 15 | ||
Endolymphatic Hydrops and CNS Disease | 16 | ||
Genetic | 16 | ||
Idiopathic | 16 | ||
Infection | 16 | ||
Neoplasm | 16 | ||
Noise-Induced Hearing Loss | 16 | ||
Ototoxicity | 17 | ||
Trauma | 17 | ||
Vascular | 17 | ||
EVIDENCE-BASED CLINICAL ASSESSMENT | 17 | ||
Audiometric Testing | 17 | ||
Auditory Brainstem Response | 17 | ||
Vestibular Assessment | 18 | ||
Magnetic Resonance Imaging | 18 | ||
Computed Tomography | 18 | ||
Laboratory Tests | 18 | ||
EVIDENCED-BASED MANAGEMENT | 19 | ||
Autoimmune Inner Ear Disease | 19 | ||
Intratympanic steroids | 20 | ||
Antivirals | 20 | ||
Hyperbaric oxygen | 20 | ||
Rheopheresis | 21 | ||
BOTTOM LINE | 21 | ||
CRITICAL POINTS WITH EVIDENCE | 21 | ||
REFERENCES | 21 | ||
3 - Laryngopharyngeal Reflux in Chronic Rhinosinusitis: Evidence-Based Practice | 25 | ||
INTRODUCTION | 25 | ||
EPIDEMIOLOGIC ASSOCIATION BETWEEN REFLUX AND CHRONIC RHINOSINUSITIS | 25 | ||
PATHOGENIC ROLE OF REFLUX IN CHRONIC RHINOSINUSITIS | 27 | ||
PROGNOSTIC IMPACT OF REFLUX ON CHRONIC RHINOSINUSITIS SYMPTOMS | 30 | ||
EFFECT OF MEDICAL TREATMENT OF REFLUX ON CHRONIC RHINOSINUSITIS SYMPTOMS | 32 | ||
REFERENCES | 33 | ||
4 - Evidence-Based Practice: Balloon Catheter Dilation in Rhinology | 37 | ||
BACKGROUND ON CHRONIC RHINOSINUSITIS | 37 | ||
OVERVIEW OF BALLOON CATHETER TECHNOLOGIES | 38 | ||
Balloon Sinuplasty | 38 | ||
LacriCATH | 38 | ||
FinESS | 38 | ||
EVIDENCE-BASED CLINICAL ASSESSMENT | 39 | ||
EVIDENCE-BASED SURGICAL TECHNIQUE | 39 | ||
Adult Medically Refractory Chronic Rhinosinusitis | 39 | ||
Pediatric Medically Refractory Chronic Rhinosinusitis | 42 | ||
Frontal Sinus Disease | 43 | ||
WHAT DOES THE EVIDENCE TELL US? | 45 | ||
REFERENCES | 45 | ||
5 - Epistaxis: An Update on Contemporary Evidence-Based Approach | 49 | ||
INTRODUCTION | 49 | ||
METHODS | 49 | ||
RESULTS–A MANAGEMENT PATHWAY | 49 | ||
Management | 49 | ||
Pathway progression—uncontrolled epistaxis | 49 | ||
Protocol completion—treated epistaxis | 49 | ||
Refractory Acute Epistaxis | 54 | ||
Adjunctive Treatments | 54 | ||
Preventing Epistaxis Deaths | 54 | ||
DISCUSSION | 55 | ||
REFERENCES | 55 | ||
6 - Evidence-Based Practice: Functional Rhinoplasty | 59 | ||
BACKGROUND | 59 | ||
Scope of the Problem | 59 | ||
Anatomy and Pathophysiology | 59 | ||
EVALUATION OF NASAL OBSTRUCTION | 60 | ||
History and Physical Examination | 60 | ||
Endoscopy and Imaging | 61 | ||
Objective Measures of Nasal Obstruction | 62 | ||
NONSURGICAL MANAGEMENT OF THE NASAL VALVE | 63 | ||
SURGICAL MANAGEMENT OF THE NASAL VALVE | 63 | ||
Perioperative Management | 63 | ||
Batten grafts | 64 | ||
Lateral crural reposition and struts | 65 | ||
Local cartilage flaps | 66 | ||
Butterfly grafts | 66 | ||
Suturing techniques | 67 | ||
Minimally invasive techniques | 67 | ||
Outcomes | 67 | ||
Complications | 68 | ||
BOTTOM LINE | 68 | ||
REFERENCES | 68 | ||
7 - Evidence-Based Practice: Sublingual Immunotherapy for Allergic Rhinitis | 73 | ||
DISEASE OVERVIEW—ALLERGIC RHINITIS | 73 | ||
EVIDENCE-BASED MEDICAL MANAGEMENT—SUBLINGUAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS | 75 | ||
Allergen-Specific Immunotherapy | 75 | ||
Pediatric Populations | 76 | ||
Single- Versus Multiantigen Sublingual Immunotherapy | 77 | ||
Safety of Sublingual Immunotherapy | 77 | ||
Sublingual Immunotherapy Dosing | 78 | ||
Emerging Therapies | 78 | ||
BOTTOM LINE: WHAT DOES THE EVIDENCE TELL US? | 78 | ||
REFERENCES | 79 | ||
8 - Evidence-Based Practice: Pediatric Obstructive Sleep Apnea | 83 | ||
OVERVIEW | 83 | ||
EPIDEMIOLOGY OF PEDIATRIC SLEEP DISORDERS | 83 | ||
POTENTIAL CONSEQUENCES OF OBSTRUCTIVE SLEEP APNEA SYNDROMES | 84 | ||
Cardiometabolic Health | 84 | ||
Hyperactivity and Daytime Disturbances | 85 | ||
Effects on Academic Performance and Learning | 86 | ||
UTILITY OF POLYSOMNOGRAPHY | 86 | ||
OBESITY AND SLEEP-DISORDERED BREATHING | 86 | ||
MEDICAL MANAGEMENT OF SLEEP-DISORDERED BREATHING | 87 | ||
SLEEP ENDOSCOPY | 87 | ||
RESIDUAL OBSTRUCTIVE SLEEP APNEA AFTER ADENOTONSILLECTOMY | 88 | ||
ANALGESIA FOLLOWING ADENOTONSILLECTOMY | 89 | ||
METHOD OF TONSILLECTOMY | 89 | ||
CONCLUSIONS | 89 | ||
REFERENCES | 90 | ||
9 - Evidence-Based Practice: Pediatric Tonsillectomy | 93 | ||
OVERVIEW | 93 | ||
EVIDENCE-BASED CLINICAL ASSESSMENT | 93 | ||
Indications for Tonsillectomy | 93 | ||
Patient Assessment | 95 | ||
Polysomnography | 95 | ||
EVIDENCE-BASED SURGICAL TECHNIQUE FOR TONSILLECTOMY | 96 | ||
Instrumentation | 96 | ||
Technique: Partial Intracapsular Tonsillectomy Versus Total Tonsillectomy | 96 | ||
EVIDENCE-BASED PERIOPERATIVE MANAGEMENT FOR TONSILLECTOMY | 96 | ||
Dexamethasone | 96 | ||
Perioperative Antibiotics | 97 | ||
Postoperative Hospitalization | 97 | ||
Pain Control | 97 | ||
Outcomes Assessment | 98 | ||
CONCLUSIONS | 99 | ||
REFERENCES | 99 | ||
10 - Evidence-Based Practice: Evaluation and Management of Unilateral Vocal Fold Paralysis | 103 | ||
PROBLEM OVERVIEW | 103 | ||
Etiology (Levels 3–4) | 103 | ||
Evolving Distribution of Etiologies (Levels 3–4) | 104 | ||
Laterality and Natural History of Idiopathic Unilateral Vocal Fold Paralysis (Level 4) | 105 | ||
Symptoms (Levels 3–4) | 105 | ||
Quality of Life at Presentation (Levels 3–4) | 105 | ||
EVIDENCE-BASED CLINICAL ASSESSMENT | 106 | ||
Examination (Levels 3–5) | 106 | ||
Imaging (Levels 3–5) | 107 | ||
Serology (Levels 3–5) | 107 | ||
Laryngeal Electromyography (Levels 2–5) | 108 | ||
FUTURE HORIZONS | 115 | ||
BOTTOM LINE: WHAT DOES THE EVIDENCE TELL US? | 116 | ||
ACKNOWLEDGMENTS | 116 | ||
REFERENCES | 116 | ||
11 - Evidence-Based Practice: Management of Hoarseness/Dysphonia | 125 | ||
OVERVIEW | 125 | ||
EVIDENCE-BASED CLINICAL ASSESSMENT | 125 | ||
Assessment of Vocal Fold Vibration | 127 | ||
Laryngostroboscopy | 127 | ||
High-speed digital imaging | 127 | ||
Direct laryngoscopy | 127 | ||
Other Techniques to Assess Vocal Fold Motion | 128 | ||
Ultrasonography | 128 | ||
Optical coherence tomography | 128 | ||
Ancillary Diagnostic Testing for Dysphonia | 128 | ||
Laryngeal electromyography | 128 | ||
Radiographic imaging | 129 | ||
Measurement of Degree of Dysphonia | 129 | ||
Patient-reported outcome measures | 129 | ||
Clinician-rated measures | 130 | ||
EVIDENCE-BASED MANAGEMENT OF DYSPHONIA | 130 | ||
Functional Voice Disorders | 130 | ||
Voice therapy | 130 | ||
Medical therapy | 130 | ||
Surgical therapy | 131 | ||
Inflammatory Laryngeal Pathology | 131 | ||
Voice therapy | 131 | ||
Medical therapy | 131 | ||
Benign Laryngeal Lesions | 133 | ||
Voice therapy | 133 | ||
Medical therapy | 134 | ||
Surgical therapy | 134 | ||
Laser treatment | 134 | ||
Glottic Insufficiency | 134 | ||
Voice therapy | 135 | ||
Medical therapy | 135 | ||
Surgical therapy | 135 | ||
WHAT THE EVIDENCE TELLS US (THE BOTTOM LINE) | 137 | ||
CRITICAL POINTS | 137 | ||
REFERENCES | 138 | ||
12 - Evidence-Based Practice: Endoscopic Skull Base Resection for Malignancy | 149 | ||
OVERVIEW OF SINONASAL AND SKULL BASE MALIGNANCY | 149 | ||
ESTHESIONEUROBLASTOMA | 149 | ||
Incidence and Epidemiology | 149 | ||
Clinical Assessment | 150 | ||
Surgical Management of Esthesioneuroblastoma | 150 | ||
SINONASAL MELANOMA | 151 | ||
Incidence and Epidemiology | 151 | ||
Clinical Assessment | 152 | ||
Surgical Management of Sinonasal Mucosal Melanoma | 152 | ||
NASOPHARYNGEAL CARCINOMA | 153 | ||
Incidence and Epidemiology | 153 | ||
Clinical Assessment | 153 | ||
Surgical Management of Nasopharyngeal Carcinoma | 154 | ||
SINONASAL ADENOCARCINOMA | 154 | ||
Incidence and Epidemiology | 154 | ||
Clinical Assessment | 156 | ||
Surgical Management of Sinonasal Adenocarcinoma | 156 | ||
SINONASAL UNDIFFERENTIATED CARCINOMA | 157 | ||
Incidence and Epidemiology | 157 | ||
Clinical Assessment | 157 | ||
Surgical Management of Sinonasal Undifferentiated Carcinoma | 157 | ||
SUMMARY AND CONCLUSIONS | 158 | ||
REFERENCES | 158 | ||
13 - Evidence-Based Practice: Management of Glottic Cancer | 163 | ||
DISEASE OVERVIEW: MAIN QUESTIONS IN GLOTTIC CARCINOMA | 163 | ||
EVIDENCE-BASED INITIAL WORKUP | 163 | ||
Clinical Examination | 163 | ||
Imaging Studies | 164 | ||
MANAGEMENT OF EARLY STAGE GLOTTIC CANCER (TIST1) | 164 | ||
MANAGEMENT OF T2 GLOTTIC CANCER | 165 | ||
MANAGEMENT OF THE NECK IN T1T2CN0 GLOTTIC CANCER | 165 | ||
MANAGEMENT OF ADVANCED LESIONS T3T4 | 166 | ||
EVIDENCE BASE FOR EXCLUSIVE CHEMOTHERAPY FOR GLOTTIC CARCINOMA | 167 | ||
EVIDENCE BASE FOR THE ROLE OF HUMAN PAPILLOMAVIRUS IN LARYNGEAL SQUAMOUS CELL CARCINOMA | 168 | ||
WHAT DOES THE EVIDENCE REALLY SAY? | 168 | ||
REFERENCES | 169 | ||
14 - Evidence-Based Practice: Management of Well-Differentiated Thyroid Cancer | 175 | ||
INTRODUCTION | 175 | ||
CLINICAL ASSESSMENT FOR THYROID CANCER | 175 | ||
Clinical Examination Including Voice Assessment | 175 | ||
Computed tomography, magnetic resonance imaging, and positron emission tomography | 176 | ||
Genetic Testing | 176 | ||
TREATMENT OF DIFFERENTIATED THYROID CANCER | 177 | ||
Tumor involvement of the recurrent laryngeal nerve | 178 | ||
Management of the central lymph node compartment | 178 | ||
Management of the lateral lymph node compartment | 179 | ||
Indications for Postoperative Radioactive Iodine Treatment | 179 | ||
STAGING SYSTEMS AND RISK STRATIFICATION | 180 | ||
MANAGEMENT OF RECURRENCE | 181 | ||
REFERENCES | 181 | ||
Index | 185 | ||
A | 185 | ||
B | 185 | ||
C | 186 | ||
D | 186 | ||
E | 186 | ||
F | 187 | ||
G | 187 | ||
H | 188 | ||
I | 188 | ||
K | 188 | ||
L | 188 | ||
M | 189 | ||
N | 189 | ||
O | 189 | ||
P | 189 | ||
Q | 190 | ||
R | 190 | ||
S | 191 | ||
T | 191 | ||
U | 192 | ||
V | 192 | ||
W | 192 | ||
Y | 192 |